The Triple Aim for Neonatal Abstinence Syndrome

Journal of Pediatrics

Volumn 167, Issue 6, 2015, Pages 1189-1191

  Patrick, Stephen W ^a,b  

^a VANDERBILT UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHADONE; NARCOTIC ANALGESIC AGENT;

HUMAN; NEONATAL ABSTINENCE SYNDROME;

ANALGESICS, OPIOID; HUMANS; METHADONE; NEONATAL ABSTINENCE SYNDROME;

EID: 84965184311     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2015.09.047     Document Type: Editorial

References (19)

1. Patrick, S.W., Dudley, J., Martin, P.R., Harrell, F.E., Warren, M.D., Hartmann, K.E., et al. Prescription opioid epidemic and infant outcomes. Pediatrics 135 (2015), 842–850.
2. Patrick, S.W., Davis, M.M., Lehman, C.U., Cooper, W.O., Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States, 2009 to 2012. J Perinatol 35 (2015), 650–655.
3. Wiles, J.R., Isemann, B., Mizuno, T., Tabangin, M.E., Ward, L.P., Akinbi, H., et al. Pharmacokinetics of oral methadone in the treatment of neonatal abstinence syndrome: a pilot study. J Pediatr 167 (2015), 1214–1220.
4. Osborn, D.A., Jeffery, H.E., Cole, M.J., Opiate treatment for opiate withdrawal in newborn infants. Cochrane Database Syst Rev, 2010, CD002059.
5. Hudak, M.L., Tan, R.C., Neonatal drug withdrawal. Pediatrics 129 (2012), e540–e560.
6. Tolia, V.N., Patrick, S.W., Bennett, M.M., Murthy, K., Sousa, J., Smith, P.B., et al. Increasing incidence of the neonatal abstinence syndrome in US neonatal ICUs. N Engl J Med 372 (2015), 2118–2126.
7. Patrick, S.W., Kaplan, H.C., Passarella, M., Davis, M.M., Lorch, S.A., Variation in treatment of neonatal abstinence syndrome in US children's hospitals, 2004-2011. J Perinatol 34 (2014), 867–872.
8. Brown, M.S., Hayes, M.J., Thornton, L.M., Methadone versus morphine for treatment of neonatal abstinence syndrome: a prospective randomized clinical trial. J Perinatol 35 (2014), 278–283.
9. Berwick, D.M., Nolan, T.W., Whittington, J., The triple aim: care, health, and cost. Health Aff (Millwood) 27 (2008), 759–769.
10. Fleming C. Berwick brings the “triple aim” to CMS. http://healthaffairs.org/blog/2010/09/14/berwick-brings-the-triple-aim-to-cms. Accessed September 1, 2015.
11. Sarkar, S., Donn, S.M., Management of neonatal abstinence syndrome in neonatal intensive care units: a national survey. J Perinatol 26 (2006), 15–17.
12. Finnegan, L.P., Kron, R.E., Connaughton, J.F., Emich, J.P., Assessment and treatment of abstinence in the infant of the drug-dependent mother. Int J Clin Pharmacol Biopharm 12 (1975), 19–32.
13. Bagley, S.M., Wachman, E.M., Holland, E., Brogly, S.B., Review of the assessment and management of neonatal abstinence syndrome. Addict Sci Clin Pract, 9, 2014, 19.
14. Institute of Medicine, Committee on Quality of Health Care in America. Crossing the quality chasm: A new health system for the 21st century. 2001, National Academies Press, Washington (DC).
15. Epstein, R.A., Bobo, W.V., Martin, P.R., Morrow, J.A., Wang, W., Chandrasekar, R., et al. Increasing pregnancy-related use of prescribed opioid analgesics. Ann Epidemiol 23 (2013), 498–503.
16. US Government Accountability Office. Prenatal drug use and newborn health: federal efforts need better coordination and planning. http://www.gao.gov/assets/670/668385.pdf. Accessed September 1, 2015.
17. Hall, E.S., Wexelblatt, S.L., Crowley, M., Grow, J.L., Jasin, L.R., Klebanoff, M.A., et al. A multicenter cohort study of treatments and hospital outcomes in neonatal abstinence syndrome. Pediatrics 134 (2014), e527–e534.
18. Vermont Oxford Network. A universal training solution: improving outcomes for infants and families affected by neonatal abstinence syndrome (NAS). https://public.vtoxford.org/quality-education/inicq-2015-nas-universal-training/. Accessed September 3, 2015.
19. Tennessee Initiative for Perinatal Quality Care. Neonatal abstinence syndrome (NAS). https://tipqc.org/?page_id=71. Accessed September 3, 2015.